Profile

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Nambulli S, Escriou N, Rennick LJ, Demers MJ, Tilston-Lunel NL, McElroy AK, Barbeau DJ, Crossland NA, Hoehl RM, Schrauf S, White AG, Borish HJ, Tomko JA, Frye LJ, Scanga CA, Flynn JL, Martin A, Gerke C, Hartman AL, Duprex WP. A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: protection of African green monkeys from COVID-19 disease. J Virol. 2024 May 14; 98(5):e0176223.View Related Profiles. PMID: 38563762; PMCID: PMC11092351; DOI: 10.1128/jvi.01762-23;
     
  2. Schmitz KS, Rennick LJ, Tilston-Lunel NL, Comvalius AD, Laksono BM, Geers D, van Run P, de Vries RD, de Swart RL, Duprex WP. Rational attenuation of canine distemper virus (CDV) to develop a morbillivirus animal model that mimics measles in humans. J Virol. 2024 Mar 19; 98(3):e0185023. PMID: 38415596; PMCID: PMC10949419; DOI: 10.1128/jvi.01850-23;
     
  3. Rennick LJ, Duprex WP, Tilston-Lunel NL. Generation of Defective Interfering Particles of Morbilliviruses Using Reverse Genetics. Methods Mol Biol. 2024; 2808:57-70. PMID: 38743362
     
  4. Guseman AJ, Rennick LJ, Nambulli S, Roy CN, Martinez DR, Yang DT, Bhinderwala F, Vergara S, Schaefer A, Baric RS, Ambrose Z, Duprex WP, Gronenborn AM. Targeting spike glycans to inhibit SARS-CoV2 viral entry. Proc Natl Acad Sci U S A. 2023 Sep 19; 120(38):e2301518120.View Related Profiles. PMID: 37695910; PMCID: PMC10515186; DOI: 10.1073/pnas.2301518120;
     
  5. Roelofs D, Schmitz KS, van Amerongen G, Rijsbergen LC, Laksono BM, Comvalius AD, Nambulli S, Rennick LJ, van Run P, Duprex WP, van den Brand JMA, de Swart RL, de Vries RD. Inoculation of raccoons with a wild-type-based recombinant canine distemper virus results in viremia, lymphopenia, fever, and widespread histological lesions. mSphere. 2023 Aug 24; 8(4):e0014423.View Related Profiles. PMID: 37314205; PMCID: PMC10449507; DOI: 10.1128/msphere.00144-23;
     
  6. Guseman AJ, Rennick LJ, Nambulli S, Roy CN, Martinez DR, Yang DT, Bhinderwhala F, Vergara S, Baric RS, Ambrose Z, Duprex WP, Gronenborn AM. Targeting Spike Glycans to Inhibit SARS-CoV2 Viral Entry. bioRxiv. 2022 Dec 22.View Related Profiles. PMID: 36597530; PMCID: PMC9810211; DOI: 10.1101/2022.12.22.521642;
     
  7. Nambulli S, Rennick LJ, Acciardo AS, Tilston-Lunel NL, Ho G, Crossland NA, Hardcastle K, Nieto B, Bainbridge G, Williams T, Sharp CR, Duprex WP. FeMV is a cathepsin-dependent unique morbillivirus infecting the kidneys of domestic cats. Proc Natl Acad Sci U S A. 2022 Oct 25; 119(43):e2209405119.View Related Profiles. PMID: 36251995; PMCID: PMC9618091; DOI: 10.1073/pnas.2209405119;
     
  8. Norris MJ, Husby ML, Kiosses WB, Yin J, Saxena R, Rennick LJ, Heiner A, Harkins SS, Pokhrel R, Schendel SL, Hastie KM, Landeras-Bueno S, Salie ZL, Lee B, Chapagain PP, Maisner A, Duprex WP, Stahelin RV, Saphire EO. Measles and Nipah virus assembly: Specific lipid binding drives matrix polymerization. Sci Adv. 2022 Jul 22; 8(29):eabn1440. PMID: 35857835; PMCID: PMC9299542; DOI: 10.1126/sciadv.abn1440;
     
  9. Tilston-Lunel NL, Welch SR, Nambulli S, de Vries RD, Ho GW, Wentworth DE, Shabman R, Nichol ST, Spiropoulou CF, de Swart RL, Rennick LJ, Duprex WP. Sustained Replication of Synthetic Canine Distemper Virus Defective Genomes In Vitro and In Vivo. mSphere. 2021 10 27; 6(5):e0053721.View Related Profiles. PMID: 34550005; PMCID: PMC8550193; DOI: 10.1128/mSphere.00537-21;
     
  10. Hensley MK, Bain WG, Jacobs J, Nambulli S, Parikh U, Cillo A, Staines B, Heaps A, Sobolewski MD, Rennick LJ, Macatangay BJC, Klamar-Blain C, Kitsios GD, Methé B, Somasundaram A, Bruno TC, Cardello C, Shan F, Workman C, Ray P, Ray A, Lee J, Sethi R, Schwarzmann WE, Ladinsky MS, Bjorkman PJ, Vignali DA, Duprex WP, Agha ME, Mellors JW, McCormick KD, Morris A, Haidar G. Intractable Coronavirus Disease 2019 (COVID-19) and Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Replication in a Chimeric Antigen Receptor-Modified T-Cell Therapy Recipient: A Case Study. Clin Infect Dis. 2021 08 02; 73(3):e815-e821.View Related Profiles. PMID: 33507235; PMCID: PMC7929077; DOI: 10.1093/cid/ciab072;
     
Showing 10 of 39 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.



Contact for Mentoring: